Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inclacumab in Non-STEMI patients undergoing PCI
NCT01327183Phase 2Completed
- Sponsor
- Roche
- Start
- May 2011
- Primary completion
- Oct 2012
- Modality
- Monoclonal Antibodies
- Countries
- 4
01
Overview
A Phase 2 trial of inclacumab in non-ST-elevation myocardial infarction (NSTEMI), sponsored by Roche. Started May 2011; status: completed.
02
Drugs
inclacumab
03
Conditions
non-ST-elevation myocardial infarction (NSTEMI)
Beyond the preview
Go deeper on NCT01327183.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01327183.